Publications by authors named "Mao-Lin Yan"

Claim this Profile
L
Letter to the Editor: Immortal time bias in the management of patients with HCC who achieved CR following immunotherapy-based systemic therapy.
Zhen-Xin Zeng, Yi-Nan Li, Jun-Yi Wu, Jia-Yi Wu, Mao-Lin Yan

Hepatology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HAIC plus lenvatinib and PD-1 inhibitors for hepatocellular carcinoma with Vp4 portal vein tumor thrombus.
Zhen-Xin Zeng, Jun-Yi Wu, Jia-Yi Wu, Mao-Lin Yan

Hepatol Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and outcomes of early and late recurrence after hepatectomy for hepatocellular carcinoma with microvascular invasion: a multicenter study in China.
Xiu-Ping Zhang, Tian-Chen Zhang, Fei-Fan Wu, Zhen-Qi Li, Zhao-Hui Xiao, Mao-Lin Yan

Hepatol Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Clinical Complete Response for Patients with Initially Unresectable Hepatocellular Carcinoma after Conversion with Triple Therapy.
Jun-Yi Wu, Zhen-Xin Zeng, Yi-Nan Li, Zhi-Bo Zhang, Shao-Wu Zhuang, Mao-Lin Yan

Liver Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 Inhibitors.
Shao-Ming Wei, Zhen-Xin Zeng, Rong-Jian Pan, Jia-Yi Wu, Jun-Yi Wu, Mao-Lin Yan

J Inflamm Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).
Yu Yang, Juxian Sun, Jianqiang Cai, Minshan Chen, Chaoliu Dai, Yan Jin, Mao-Lin Yan

Liver Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival in advanced unresectable HCC treated with transcatheter arterial chemoembolization combined with lenvatinib and PD-1 inhibitors.
Zhen-Xin Zeng, Hua-Chun Song, Yi-Nan Li, Jia-Yi Wu, Dong Liang, Mao-Lin Yan

Oncologist· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiologic complete response after conversion therapy for hepatocellular carcinoma: is liver transplantation necessary?
Chen-Hao Gao, Lin Ping Cao, Shu-Qun Cheng, Lei Wang, Ji-Zhou Wang, Mao-Lin Yan, Zhe Yang

Hepatobiliary Surg Nutr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiofrequency ablation versus stereotactic body radiotherapy for recurrent hepatocellular carcinoma: a multicenter, propensity score matching analysis.
Zi-Hui Ma, Xiao-Lu Lin, Feng-Hua Liu, Jing-Lei Zhang, Mao-Lin Yan, Yan Meng

BMC Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastases: A Multicenter Retrospective Study.
De-Yi Liu, Yi-Nan Li, Jia-Yi Wu, Zhen-Xin Zeng, Yang-Kai Fu, Mao-Lin Yan

J Hepatocell Carcinoma· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed".
Zhen-Xin Zeng, Jia-Yi Wu, Shao-Wu Zhuang, Mao-Lin Yan

Hepatol Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapy Consisting of Transarterial Chemoembolization, Lenvatinib, and Programmed Cell Death Protein 1 Blockade for Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus: A Case Series Study and Literature Review.
Yang-Kai Fu, Yi-Nan Li, De-Yi Liu, Zhen-Xin Zeng, Jia-Yi Wu, Mao-Lin Yan

Oncol Res Treat· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery.
Zhen-Xin Zeng, Jia-Yi Wu, Jun-Yi Wu, Zhi-Bo Zhang, Kai Wang, Yang-Kai Fu, Mao-Lin Yan

Liver Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study.
Zhong-Tai Lin, Shao-Ming Wei, Jun-Yi Wu, Zhi-Bo Zhang, Shuang-Jia Wang, Yang-Kai Fu, Mao-Lin Yan

J Hepatocell Carcinoma· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody.
Lei Wang, Jin-Kai Feng, Chong-De Lu, Jia-Yi Wu, Bin Zhou, Mao-Lin Yan

Oncologist· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new scoring system for predicting the outcome of hepatocellular carcinoma patients without microvascular invasion-a large-scale multicentre study.
Ju-Xian Sun, Zhe Yang, Jia-Yi Wu, Jie Shi, Hong-Ming Yu, Mao-Lin Yan

HPB (Oxford)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Impact of Salvage Surgery in Unresectable Hepatocellular Carcinoma After Conversion Therapy: Should it be Recommended?
Jun-Yi Wu, Jia-Yi Wu, Yang-Kai Fu, Mao-Lin Yan

Ann Surg Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Jun-Yi Wu, Jia-Yi Wu, Yang-Kai Fu, Xiang-Ye Ou, Shu-Qun Li, Mao-Lin Yan

Ann Surg Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors.
Zhen-Xin Zeng, Jia-Yi Wu, Jun-Yi Wu, Yi-Nan Li, Yang-Kai Fu, Mao-Lin Yan

Hepatol Int· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
ï
A new species and a replacement name in (Apocynaceae, Asclepiadeae) from China.
Miao Liao, Si-Jin Zeng, Lin-Ya Zeng, Hai-Jun Yin, Mao-Lin Yan

PhytoKeys· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma: a propensity score matching analysis.
Yi-Nan Li, Shao-Ming Wei, Yang-Kai Fu, Zhen-Xin Zeng, Li-Ming Huang, Mao-Lin Yan

Front Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu, Mao-Lin Yan, Yan-Fang Liu

Nat Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study.
Xu-Kun Wu, Lan-Fang Yang, Yu-Feng Chen, Zhong-Wu Chen, Hao Lu, Mao-Lin Yan

EClinicalMedicine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?
Jia-Yi Wu, Jun-Yi Wu, De-Yi Liu, Han Li, Shao-Wu Zhuang, Mao-Lin Yan

J Hepatocell Carcinoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus: a multicenter study.
Li-Ming Huang, Zhen-Xin Zeng, Jun-Yi Wu, Yi-Nan Li, Jin-Xiu Wang, Yang-Kai Fu, Mao-Lin Yan

Front Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis